Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer
about
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissueThe potential utility of telomere-related markers for cancer diagnosis.Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.Markers of field cancerization: proposed clinical applications in prostate biopsiesProstate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.Prostate cancer: the need for biomarkers and new therapeutic targets.Organ-wide telomeric status in diseased and disease-free prostatic tissues.Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer.Telomere length analysis and preterm infant health: the importance of assay design in the search for novel biomarkers.Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.Genomic predictors of prostate cancer therapy outcomes.Toxicogenomic evaluation of chemically induced chromosomal imbalance using DNA image analysis.
P2860
Q35175108-C7B03382-07A4-40A2-9668-9C661C8F8398Q35216054-C05AA1ED-48BC-45F4-8DE8-EAC13C4C10FDQ35762852-239FAD15-6EB4-4375-969B-02BCB1B28FEFQ35923141-737C162A-9E06-48D6-893A-7BA3F01B98EDQ35991148-A67CBAE7-168F-4251-8E97-FE70B849D9D2Q37231116-63A29248-DEEB-4565-ABD7-C0DC254E64F0Q37476043-214A6F3A-8429-4966-9062-D1F63DEB2C00Q37577370-5AFE18DB-680E-44EF-9CAA-A422522160CDQ38088721-1ABBCD0B-B098-4C41-A04D-7A0B35405226Q38209383-8341B27F-B12E-474E-A0E5-434404D88B28Q40665254-76D988A7-3CBC-4A90-A63F-28A220ADA695Q44958045-C1396ED4-244C-42AD-87A8-D462310319F1Q53261232-C024FF06-83BF-467C-87FB-62C98B0B7882
P2860
Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Telomere DNA content in prosta ...... statectomy for prostate cancer
@ast
Telomere DNA content in prosta ...... statectomy for prostate cancer
@en
type
label
Telomere DNA content in prosta ...... statectomy for prostate cancer
@ast
Telomere DNA content in prosta ...... statectomy for prostate cancer
@en
prefLabel
Telomere DNA content in prosta ...... statectomy for prostate cancer
@ast
Telomere DNA content in prosta ...... statectomy for prostate cancer
@en
P2093
P2860
P1433
P1476
Telomere DNA content in prosta ...... statectomy for prostate cancer
@en
P2093
Anthony Y Smith
Christopher M Heaphy
Eric G Treat
Jeffrey K Griffith
Larry W Massie
Marco Bisoffi
Michael S Davis
P2860
P304
P356
10.1016/J.UROLOGY.2009.04.032
P407
P577
2009-07-16T00:00:00Z